Barclays’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-90,862
Closed -$6.16M 4506
2019
Q3
$6.16M Buy
90,862
+56,207
+162% +$3.81M ﹤0.01% 983
2019
Q2
$2.02M Buy
34,655
+6,452
+23% +$375K ﹤0.01% 1804
2019
Q1
$1.98M Buy
28,203
+17,524
+164% +$1.23M ﹤0.01% 1573
2018
Q4
$688K Sell
10,679
-189
-2% -$12.2K ﹤0.01% 2065
2018
Q3
$764K Buy
10,868
+8,526
+364% +$599K ﹤0.01% 2418
2018
Q2
$118K Sell
2,342
-5,757
-71% -$290K ﹤0.01% 2998
2018
Q1
$254K Buy
8,099
+4,835
+148% +$152K ﹤0.01% 2710
2017
Q4
$111K Buy
3,264
+2,743
+526% +$93.3K ﹤0.01% 2959
2017
Q3
$17K Sell
521
-1,661
-76% -$54.2K ﹤0.01% 3270
2017
Q2
$71K Buy
2,182
+51
+2% +$1.66K ﹤0.01% 2898
2017
Q1
$67K Sell
2,131
-3,705
-63% -$116K ﹤0.01% 2997
2016
Q4
$172K Buy
5,836
+4,544
+352% +$134K ﹤0.01% 2365
2016
Q3
$38K Buy
1,292
+1,265
+4,685% +$37.2K ﹤0.01% 2828
2016
Q2
$1K Sell
27
-1,157
-98% -$42.9K ﹤0.01% 3513
2016
Q1
$28K Buy
1,184
+595
+101% +$14.1K ﹤0.01% 2704
2015
Q4
$20K Sell
589
-8,336
-93% -$283K ﹤0.01% 2701
2015
Q3
$187K Buy
8,925
+8,513
+2,066% +$178K ﹤0.01% 2150
2015
Q2
$11K Sell
412
-553
-57% -$14.8K ﹤0.01% 3269
2015
Q1
$29K Sell
965
-1,285
-57% -$38.6K ﹤0.01% 2976
2014
Q4
$69K Sell
2,250
-1,325
-37% -$40.6K ﹤0.01% 2857
2014
Q3
$101K Sell
3,575
-3,334
-48% -$94.2K ﹤0.01% 2635
2014
Q2
$186K Buy
6,909
+2,634
+62% +$70.9K ﹤0.01% 2429
2014
Q1
$111K Buy
4,275
+1,222
+40% +$31.7K ﹤0.01% 2725
2013
Q4
$89K Sell
3,053
-958
-24% -$27.9K ﹤0.01% 3093
2013
Q3
$121K Sell
4,011
-3,785
-49% -$114K ﹤0.01% 2862
2013
Q2
$247K Buy
+7,796
New +$247K ﹤0.01% 2582